z-logo
open-access-imgOpen Access
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Author(s) -
Nick Macklon,
Richard L. Stouffer,
Linda C. Giudice,
Bart C.J.M. Fauser
Publication year - 2006
Publication title -
endocrine reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.357
H-Index - 272
eISSN - 1945-7189
pISSN - 0163-769X
DOI - 10.1210/er.2005-0015
Subject(s) - follicular phase , in vitro fertilisation , stimulation , luteal phase , embryo transfer , gonadotropin , oocyte , biology , human chorionic gonadotropin , endometrium , andrology , human fertilization , endocrinology , medicine , embryo , hormone , microbiology and biotechnology , anatomy
To allow selection of embryos for transfer after in vitro fertilization, ovarian stimulation is usually carried out with exogenous gonadotropins. To compensate for changes induced by stimulation, GnRH analog cotreatment, oral contraceptive pretreatment, late follicular phase human chorionic gonadotropin, and luteal phase progesterone supplementation are usually added. These approaches render ovarian stimulation complex and costly. The stimulation of multiple follicular development disrupts the physiology of follicular development, with consequences for the oocyte, embryo, and endometrium. In recent years, recombinant gonadotropin preparations have become available, and novel stimulation protocols with less detrimental effects have been developed. In this article, the scientific background to current approaches to ovarian stimulation for in vitro fertilization is reviewed. After a brief discussion of the relevant aspect of ovarian physiology, the development, application, and consequences of ovarian stimulation strategies are reviewed in detail.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom